Med Comms SIG

All members:


Co-chaired by Slavka Baronikova and Andrea Rossi.

Committee Members:

Andrea Bucceri and Thomas Schindler.

SIG Supporting Members:

Amanda Whereat-Terdjman, Ana Sofia Correia, Art Gertel, Aurélie Gobet, Beatrix Doerr, Catherine Hill, Chris Winchester, Diarmuid De Faoite, John Gonzalez, Laetitia Paris, Lisa Chamberlain James, Martin Delahunty, Miyuki Tauchi, Paolo Rega, Sampoorna Rappaz, Sara Ferrao, Silvia Soffia, Simon Linacre, Tim van Hartevelt, Adeline Rosenberg, Alexandra Dedman, Daniela Mitkovska, Jonathan Pitt, Maria Domenica Constantino, Mariana Rickmann, Namrata Singh, Sarah Griffiths.

E-mail address

MedComm SIG objectives:

The Medical Communications Special Interest Group (MedComm SIG) intends to support wide medical communication activities including scientific disclosure & publications, communication with the general public, and to act as a source of affordable and updated information.

Latest news and activities

Upcoming Meeting - MedComms SIG Meet & Share: AI in Medical Writing (27th September 2023)

EMWA invites you to attend this meet and share to help set the scene for forthcoming Nov 2023 Seminar on AI in Medical Writing and a Symposia focussed on AI and Medical Writing at the annual conference in May 2024. 

Dr Namrata Singh (Turacoz Group) and Martin Delahunty (Inspiring STEM) start the session with presenting some brief insights in AI tools and developments that will begin a conversation with attendees.

We encourage attendees to come prepared with experiences or knowledge of tools being used by medical writers and communicators. This will provide insights for future events and workshops to be conducted by EMWA.

If you wish to attend, email for the login details. If you have any questions in terms of copyright you would like to be discussed, please forward them to too.

Most recent activities, news items, or documents.

Subgroups and topics

Scientific Publishing

  • Key subgroup members: Andrea BucceriThomas Schindler, Lisa Chamberlain JamesArt Gertel, Andrea Rossi, Chris Winchester, Martin Delahunty, Sampoorna Rappaz, Slavka Baronikova.
  • Putting plain language summaries into perspective
  • What terminology are health journals using to refer to plain language summaries of peer reviewed manuscripts? A new open access study published last week shows 18/27 (66.7%) journals with plain language summary information in author instructions are using the term “plain language summary”. See the full study here, and key results in Table 2.



Plain Language Summaries of Scientific Publications

  • Development, best practice, accessibility and discoverability of scientific peer-reviewed publications-associated plain language summaries
  • The activities of this group include the identification of, and update on, best practice concerning writing for patients and the general public.
  • This group is working on the development of the CDISC glossary as well as interacting with EMA for the development of the EMA glossary.

Links to relevant documents

Open Science and Open Access

  • preparation of ESS and seminars at EMWA conferences and developing articles for MEW

Predatory publishing and congresses

  • development of seminars at EMWA conferences, webinars, articles for MEW as well further educational materials
  • JPS with AMWA and ISMPP, liaison on educational activities with these associations with aim to enlarge the JPS impact, knowledge and training

Links to relevant documents

Predatory Publishing Seminar

by Peter Hornung - 48th EMWA Conference, Vienna - 8th May 2019


  • Key subgroup members:  Claire Harmer, Paolo Rega, Ana Sofia Correia, Laetitia Paris, and Miyuki Tauchi



The activity of this group includes writing articles on medical translation to show the common processes between medical writing and medical translation. The aim also is to raise awareness on the medical translation among medical writers. For now, the articles are either theoretical (e.g. articles on the Latin and Greek origin of medical terms) or practical (e.g. actual examples in medical translation).


It does not include any topic on writing for regulatory authorities, but the articles might explain what a medical translator needs to be aware of when translating for health authorities.


Links to relevant documents

RWE generation, disclosure and publishing

  • Key subgroup members: Andrea Bucceri, Catherine Hill, Tim van Hartevelt



The activity includes the identification of best practices to disclose RWE data, data transparency (including the registration and publication of observational trials) and the levels of evidence.

An SBB is under preparation for next congress.


Links to relevant documents

Medical Journalism

      • Key subgroup members: Sampoorna Satheesha Rappaz, Slavka Baronikova, Miyuki Tauchi, and Silvia Soffia


Activities include instructions for EMWA members involved in fact checking initiatives are under development.

Links to relevant documents

8th EMWA Symposium

The 8th EMWA symposium day explored the challenging topic of research integrity. Research integrity is at the core of the research endeavour. It is the basis for researchers’ trust in each other and in the research record and, equally importantly, society’s trust in research.

To address mounting concern about research transparency and reproducibility, researchers, funders and journals need to work together to deliver practical solutions. Addressing research integrity is a shared task and we, as medical communicators and publication planners, have an important role to play.

At the first virtual EMWA symposium, researchers, journal publishers, the pharmaceutical industry and medical communications agencies provided their perspectives, gave their recommendations and fostered real-world discussion on research integrity – why it matters to all of us, and how we can work together to strengthen it.

    • Session 1 - Click here
    • Session 2 - Click here
    • Session 3 - Click here